-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Acute lymphocytic leukemia (ALL) is a cancer of the bone marrow that produces too many lymphocytes, which can occur in children or adults
The results of their research were published in the journal Nature Cancer
The researchers wrote: "Chemotherapy is the standard treatment for pediatric ALL, and it sometimes relapses as a feature of chemotherapy resistance
Dr.
This discovery provides the first direct genomic and experimental evidence for childhood cancers that drug-resistant mutations can be induced by chemotherapy, but they do not always appear in the diagnosis
Recurrence is still the leading cause of death in children and adolescents with ALL worldwide, although at St.
The researchers analyzed more than 1,000 samples collected from the United States, China, and Germany
Co-first author, Dr.
"This research has not only changed our thinking about the treatment of ALL, but it has also opened the door to studying how defect repair produces drug-resistant mutations," Zhou said
In the future, we may monitor the bone marrow during treatment to detect these mutation signals as early as possible to help identify high-risk patients.
Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse.